Assessing Pretransplant and Posttransplant Therapy Response in Multiple Myeloma Patients

Multiple myeloma (MM) is a hematologic cancer defined by an abnormal development of clonal plasma cells in the bone marrow, releasing vast quantities of immunoglobulins and different proteins. In the majority of patients, MM remains incurable despite decades of medical improvement and a number of tr...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Cristina Potre, Ema Borsi, Ovidiu Potre, Miruna Samfireag, Dan Costachescu, Bianca Cerbu, Felix Bratosin, Cristina Secosan, Rodica Anamaria Negrean
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Subjects:	multiple myeloma stem cell transplantation bortezomib thalidomide cyclophosphamide dexamethasone
Online Access:	https://www.mdpi.com/1718-7729/29/11/670